Claro E, García A, Picatoste F
Instituto de Biologia Fundamental Vicent Villar Palasi, Universidad Autónoma de Barcelona, Spain.
Mol Pharmacol. 1987 Sep;32(3):384-90.
Histamine stimulation of phosphoinositide breakdown has been studied in brain cortex from developing rats by measuring the accumulation of [3H]inositol monophosphate in lithium-treated slices prelabeled with [3H]inositol. Histamine stimulated phosphoinositide hydrolysis as early as day 3 after birth. The maximal response increased about 3-fold up to day 15 and remained essentially at the same level until adulthood. This developmental pattern contrasted with the 8-fold increase in [3H]mepyramine binding to histamine H1 receptors which takes place from the first to the end of the fourth week of life. Nonlinear regression analysis of concentration-effect curves for histamine generated at 6, 10, and 15 days of age revealed the presence of two components in the response, whereas a single component was found in adults. A high potency component showed EC50 values increasing from 6.4 microM at day 6 to 26.5 microM at day 15, and its contribution to the maximal response augmented from 65.8% to 78.9% during the same period. In 6-day-old animals, the H1 receptor agonists N alpha-methylhistamine and N alpha,N alpha-dimethylhistamine produced single-component responses with maximal effects similar to that estimated for the high potency component for histamine, and their relative potencies were consistent with an H1 receptor-mediated response. Inhibition constants for mepyramine, calculated from the parallel displacement of the concentration-response curves for N alpha-methylhistamine and the high potency component for histamine (6.3 nM and 10.8 nM, respectively) closely agreed with the reported affinity of rat brain H1 receptors for this compound. The low potency component of the response (EC50 = 175 microM at day 6 and EC50 = 260 microM at day 15) did not involve histamine-H2, serotonin 5-HT2, alpha 1-adrenergic, or muscarinic receptors. Pretreatment of 6-day-old cortical slices with the irreversible antagonist phenoxybenzamine, at concentrations that completely abolish [3H]mepyramine binding, left about 25% of the response to 1 mM histamine unaffected. This portion of the response, which was, moreover, insensitive to 1 microM mepyramine, was of a magnitude similar to that of the low potency component. Thus, at early stages of rat brain development, histamine induces phosphoinositide hydrolysis in part through a mechanism different from activation of H1 receptors. The loss of histamine potency and efficacy at H1 receptors throughout development is discussed and the natural occurrence of H1 receptor subsensitivity suggested.
通过测量用[³H]肌醇预标记的锂处理切片中[³H]肌醇单磷酸的积累,研究了组胺对发育中大鼠大脑皮层磷酸肌醇分解的刺激作用。组胺早在出生后第3天就刺激了磷酸肌醇水解。最大反应在出生后第15天增加了约3倍,并在成年前基本保持在同一水平。这种发育模式与[³H]美吡拉敏与组胺H1受体结合在出生后第一周到第四周结束时增加8倍形成对比。对6、10和15日龄大鼠产生的组胺浓度-效应曲线进行非线性回归分析,结果显示反应中有两个成分,而在成年大鼠中只发现一个成分。一个高效能成分的EC50值从第6天的6.4μM增加到第15天的26.5μM,在同一时期其对最大反应的贡献从65.8%增加到78.9%。在6日龄动物中,H1受体激动剂N-α-甲基组胺和N-α,N-α-二甲基组胺产生单成分反应,最大效应与组胺高效能成分的估计值相似,且它们的相对效能与H1受体介导的反应一致。由N-α-甲基组胺和组胺高效能成分的浓度-反应曲线平行位移计算得到的美吡拉敏抑制常数(分别为6.3 nM和10.8 nM)与报道的大鼠脑H1受体对该化合物的亲和力密切相符。反应的低效能成分(第6天的EC50 = 175μM,第15天的EC50 = 260μM)不涉及组胺-H2、5-羟色胺5-HT2、α1-肾上腺素能或毒蕈碱受体。用不可逆拮抗剂苯氧苄胺预处理6日龄皮层切片,在完全消除[³H]美吡拉敏结合的浓度下,1 mM组胺引起的反应仍有约25%不受影响。此外,这部分反应对1μM美吡拉敏不敏感,其大小与低效能成分相似。因此,在大鼠脑发育的早期阶段,组胺部分通过不同于H1受体激活的机制诱导磷酸肌醇水解。本文讨论了发育过程中组胺在H1受体上效力和效能的丧失,并提出了H1受体亚敏感性的自然发生情况。